APA (7th ed.) Citation

N, S., R, W., P, B., L, M., T, R., AJ, H., . . . M, M. (2025). Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study. Neurology(R) neuroimmunology & neuroinflammation, 12(4), e200395. https://doi.org/10.1212/NXI.0000000000200395

Chicago Style (17th ed.) Citation

N, Seery, et al. "Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study." Neurology(R) Neuroimmunology & Neuroinflammation 12, no. 4 (2025): e200395. https://doi.org/10.1212/NXI.0000000000200395.

MLA (9th ed.) Citation

N, Seery, et al. "Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study." Neurology(R) Neuroimmunology & Neuroinflammation, vol. 12, no. 4, 2025, p. e200395, https://doi.org/10.1212/NXI.0000000000200395.